THROMBOSIS/BLOOD
Porsolt provides models for assessing the effects of compounds and potential therapies on blood flow. These models can be used for investigating direct effects or confounding and side effects of specific treatments on blood flow.
| IN VITRO | ||
| LDL uptake | HepG2 cell line | PF 3.10 |
|
NEW! Endothelial cell activation |
HUVECs cells |
PF 2.1 |
| IN VIVO | ||
| Bleeding time (anesthetized animal) | Rat | BL 2 |
| Arterial thrombosis (FeCl2) | Rat | BL 3 |
| Venous thrombosis (FeCl2) | Rat | BL 4 |
| Arterio-venous shunt (silk thread model) | Rat | BL 5 |
Extracorporeal arterio-venous shunt (silk thread) model in the anesthetized rat
– An arterio-venous shunt is placed between the left jugular vein and the right carotid artery.
– After 20 min of extracorporeal blood circulation through the shunt, the blood flow is stopped. The wet weight of the thrombus is determined.
Both heparin and dabigatran exert their antithrombotic properties in the extracorporeal arterio-venous shunt (silk thread) rat model.
Porsolt
Z.A. de Glatigné
53940 Le Genest-Saint-Isle, France
Telephone +33 2 43 69 36 07
Contact us
WORLDWIDE PRESENCE
